Seed amplification assays (SAA) including real-time quaking-induced conversion (RT-QuiC) or protein misfolding cyclic amplification (PMCA) of amyloidogenic alpha-synuclein conformers from cerebrospinal fluid [37] may distinguish PD from MSA and have also recently been commercialized [38]. This evidence concerns the gene SNCA and Parkinson disease.